Emerging Technologies for Gut Microbiome Research

Trends in Microbiology

Volumn 24, Issue 11, 2016, Pages 887-901

  Arnold, Jason W ^a   Roach, Jeffrey ^b   Azcarate Peril, M Andrea ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

automated culturing; gut microbiome; high throughput sequencing; microbial cultivation; personalized medicine

Indexed keywords

ANTIBIOTIC AGENT; LIPOPOLYSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; RNA 16S; BIOMATERIAL;

AMINO ACID METABOLISM; AMPLICON; BACTERIOPHAGE; BACTERIUM ISOLATE; BIOENGINEERING; BIOINFORMATICS; CELL CULTURE TECHNIQUE; DENATURING GRADIENT GEL ELECTROPHORESIS; DIET SUPPLEMENTATION; DNA SEQUENCE; GENETIC PROCEDURES; GUT MICROENVIRONMENT; HIGH THROUGHPUT CULTURING; HIGH THROUGHPUT SEQUENCING; HOST IMMUNE RESPONSE; HOST RANGE; HUMAN; IMMUNE RESPONSE; IN VITRO SIMULATION; INTESTINE FLORA; LACTIC ACID BACTERIUM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; METABOLOMICS; MICROBIAL COMMUNITY; MICROBIOME ENGINEERING; MICROENVIRONMENT; MICROFLUIDICS; MOLECULAR CLONING; NONHUMAN; OPERATIONAL TAXONOMIC UNIT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; RNA GENE; SIMULATION; SPECIES COMPOSITION; TAXONOMY; TERMINAL RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WHOLE GENOME SHOTGUN SEQUENCING; BIOLOGY; HEALTH; HIGH THROUGHPUT SCREENING; MICROBIOLOGICAL EXAMINATION; RESEARCH; STEM CELL;

BIOCOMPATIBLE MATERIALS; BIOENGINEERING; CELL CULTURE TECHNIQUES; COMPUTATIONAL BIOLOGY; GASTROINTESTINAL MICROBIOME; HEALTH; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; METABOLOMICS; MICROBIOLOGICAL TECHNIQUES; RESEARCH; STEM CELLS;

EID: 84978863785     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2016.06.008     Document Type: Review

References (135)

1. 1 Savage, D.C., Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 31 (1977), 107–133.
2. 2 de Vos, W., de Vos, E., Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr. Rev. 70 (2012), 45–56.
3. 3 Kau, A.L., et al. Human nutrition, the gut microbiome and the immune system. Nature 474 (2011), 327–336.
4. 4 Sobhani, I., et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE, 6, 2011, e16393.
5. 5 Carding, S., et al. Dysbiosis of the gut microbiota in disease. Microb. Ecol. Health Dis., 26, 2015, 26191.
6. 6 Kabeerdoss, J., et al. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid. Indian J. Med. Res. 142 (2015), 23–32.
7. 7 Tremaroli, V., Backhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489 (2012), 242–249.
8. 8 Gill, S.R., et al. Metagenomic analysis of the human distal gut microbiome. Science 312 (2006), 1355–1359.
9. 9 Medina, M., et al. Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications. Clin. Exp. Immunol. 150 (2007), 531–538.
10. 10 Lee, D.K., et al. Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines. BMC Cancer, 8, 2008, 310.
11. 11 Hidalgo-Cantabrana, C., et al. Genomic overview and biological functions of exopolysaccharide biosynthesis in Bifidobacterium spp. Appl. Environ. Microbiol. 80 (2014), 9–18.
12. 12 Shen, J., et al. The gut microbiota, obesity and insulin resistance. Mol. Aspects Med. 34 (2013), 39–58.
13. 13 Naseer, M.I., et al. Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease. CNS Neurol. Disord. Drug Targets 13 (2014), 305–311.
14. 14 Azcarate-Peril, M.A., et al. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?. Am. J. Physiol. Gastrointest. Liver Physiol. 301 (2011), G401–G424.
15. 15 Panzer, A.R., Lynch, S.V., Influence and effect of the human microbiome in allergy and asthma. Curr. Opin. Rheumatol. 27 (2015), 373–380.
16. 16 Gevers, D., et al. The treatment-naïve microbiome in new-onset Crohn's disease. Cell Host Microbe 15 (2014), 382–392.
17. 17 Huttenhower, C., et al. Advancing the microbiome research community. Cell 159 (2014), 227–230.
18. 18 Eckburg, P.B., et al. Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
19. 19 Gibbons, R.J., et al. Studies of the predominant cultivable microbiota of dental plaque. Arch. Oral Biol. 9 (1964), 365–370.
20. 20 Parker, R.B., Snyder, M.L., Interactions of the oral microbiota. I. A system for the defined study of mixed cultures. Proc. Soc. Exp. Biol. Med. 108 (1961), 749–752.
21. 21 Azcarate-Peril, M.A., et al. Acute necrotizing enterocolitis of preterm piglets is characterized by dysbiosis of ileal mucosa-associated bacteria. Gut Microbes 2 (2011), 234–243.
22. 22 Donskey, C.J., et al. Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J. Microbiol. Methods 54 (2003), 249–256.
23. 23 Stewart, C.J., et al. Bacterial and fungal viability in the preterm gut: NEC and sepsis. Arch. Dis. Child. Fetal Neonatal. Ed. 98 (2013), F298–F303.
24. 24 Schuppler, M., et al. Molecular characterization of nocardioform actinomycetes in activated sludge by 16S rRNA analysis. Microbiology 141:Pt 2 (1995), 513–521.
25. 25 Blaut, M., et al. Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Br. J. Nutr. 87:Suppl. 2 (2002), S203–S211.
26. 26 Rhodes, A.N., et al. Identification of bacterial isolates obtained from intestinal contents associated with 12,000-year-old mastodon remains. Appl. Environ. Microbiol. 64 (1998), 651–658.
27. 27 Miller, C.P., et al. The effect of an antibiotic on the susceptibility of the mouse's intestinal tract to Salmonella infection. Trans. Am. Clin. Climatol. Assoc 68 (1956), 51–55 discussion 55-58.
28. 28 Santiago-Rodriguez, T.M., et al. Gut microbiome of an 11th century A.D. Pre-Columbian Andean mummy. PLoS ONE, 10, 2015, e0138135.
29. 29 Caporaso, J.G., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7 (2010), 335–336.
30. 30 Methé, B.A., et al. A framework for human microbiome research. Nature 486 (2012), 215–221.
31. 31 Li, K., et al. Analyses of the microbial diversity across the human microbiome. PLoS ONE, 7, 2012, e32118.
32. 32 Huse, S.M., et al. A core human microbiome as viewed through 16S rRNA sequence clusters. PLoS ONE, 7, 2012, e34242.
33. 33 Dechesne, A., et al. Underestimation of ammonia-oxidizing bacteria abundance by amplification bias in amoA-targeted Qpcr. Microb. Biotechnol. 9 (2016), 519–524.
34. 34 O'Donnell, J.L., et al. Indexed PCR primers induce template-specific bias in large-scale DNA sequencing studies. PLoS ONE, 11, 2016, e0148698.
35. 35 Hiergeist, A., Reischl, U., Multicenter quality assessment of 16S ribosomal DNA-sequencing for microbiome analyses reveals high inter-center variability. Int. J. Med. Microbiol, 2016, 10.1016/j.ijmm.2016.03.005 Published online March 21, 2016.
36. 36 Palmero, D., et al. Fungal microbiota from rain water and pathogenicity of Fusarium species isolated from atmospheric dust and rainfall dust. J. Ind. Microbiol. Biotechnol. 38 (2011), 13–20.
37. 37 Reyes, A., et al. Gut DNA viromes of Malawian twins discordant for severe acute malnutrition. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 11941–11946.
38. 38 Reyes, A., et al. Viruses in the fecal microbiota of monozygotic twins and their mothers. Nature 466 (2010), 334–338.
39. 39 Foca, A., Liberto, M.C., Gut inflammation and immunity: what is the role of the human gut virome?. Mediators Inflamm., 2015, 10.1155/2015/326032 Published online April 7, 2015.
40. 40 Mills, S., et al. Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes 4 (2013), 4–16.
41. 41 Kanehisa, M., et al. The KEGG resource for deciphering the genome. Nucleic Acids Res. 32:Database issue (2004), D277–D280.
42. 42 Hollister, E.B., et al. Structure and function of the healthy pre-adolescent pediatric gut microbiome. Microbiome, 3, 2015, 36.
43. 43 Morgan, X.C., Huttenhower, C., Meta'omic analytic techniques for studying the intestinal microbiome. Gastroenterology, 146, 2014 1437-1448.e1.
44. 44 Gosalbes, M., et al. Metatranscriptomic approach to analyze the functional human gut microbiota. PLoS ONE, 6, 2011, e17447.
45. 45 Franzosa, E.A., et al. Relating the metatranscriptome and metagenome of the human gut. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), E2329–E2338.
46. 46 El Aidy, S., Kleerebezem, M., Molecular signatures for the dynamic process of establishing intestinal host-microbial homeostasis: potential for disease diagnostics?. Curr. Opin. Gastroenterol. 29 (2013), 621–627.
47. 47 Santiago-Rodriguez, T.M., et al. Transcriptome analysis of bacteriophage communities in periodontal health and disease. BMC Genomics, 16, 2015, 549.
48. 48 Camp, J.G., et al. Microbiota modulate transcription in the intestinal epithelium without remodeling the accessible chromatin landscape. Genome Res. 24 (2014), 1504–1516.
49. 49 Bach Knudsen, K.E., Microbial degradation of whole-grain complex carbohydrates and impact on short-chain fatty acids and health. Adv. Nutr. 6 (2015), 206–213.
50. 50 MacFabe, D.F., Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders. Microb. Ecol. Health Dis., 26, 2015, 28177.
51. 51 Sivaprakasam, S., et al. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacol. Ther., 2016, 10.1016/j.pharmthera.2016.04.007 Published online April 23, 2016.
52. 52 Pusch, W., Kostrzewa, M., Application of MALDI-TOF mass spectrometry in screening and diagnostic research. Curr. Pharm. Des. 11 (2005), 2577–2591.
53. 53 Villas-Boas, S.G., et al. Mass spectrometry in metabolome analysis. Mass Spectrom. Rev. 24 (2005), 613–646.
54. 54 Tang, J., Microbial metabolomics. Curr. Genomics 12 (2011), 391–403.
55. 55 Goodman, A.L., et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 6252–6257.
56. 56 Faith, J.J., et al. Creating and characterizing communities of human gut microbes in gnotobiotic mice. ISME J. 4 (2010), 1094–1098.
57. 57 Faith, J.J., et al. Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci. Transl. Med., 6, 2014, 220ra11.
58. 58 Turnbaugh, P.J., et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med., 1, 2009, 6ra14.
59. 59 Connon, S.A., Giovannoni, S.J., High-throughput methods for culturing microorganisms in very-low-nutrient media yield diverse new marine isolates. Appl. Environ. Microbiol. 68 (2002), 3878–3885.
60. 60 Nichols, D., et al. Use of ichip for high-throughput in situ cultivation of “uncultivable” microbial species. Appl. Environ. Microbiol. 76 (2010), 2445–2450.
61. 61 Jung, D., et al. Application of a new cultivation technology, I-tip, for studying microbial diversity in freshwater sponges of Lake Baikal, Russia. FEMS Microbiol. Ecol. 90 (2014), 417–423.
62. 62 Wang, B.L., et al. Microfluidic high-throughput culturing of single cells for selection based on extracellular metabolite production or consumption. Nat. Biotechnol. 32 (2014), 473–478.
63. 63 Adamberg, S., et al. Survival and synergistic growth of mixed cultures of bifidobacteria and lactobacilli combined with prebiotic oligosaccharides in a gastrointestinal tract simulator. Microb. Ecol. Health Dis., 2014, 10.3402/mehd.v25.23062 Published online July 15, 2014.
64. 64 Possemiers, S., et al. PCR-DGGE-based quantification of stability of the microbial community in a simulator of the human intestinal microbial ecosystem. FEMS Microbiol. Ecol. 49 (2004), 495–507.
65. 65 McDonald, J.A., et al. Simulating distal gut mucosal and luminal communities using packed-column biofilm reactors and an in vitro chemostat model. J. Microbiol. Methods 108 (2015), 36–44.
66. 66 Petrof, E.O., Khoruts, A., From stool transplants to next-generation microbiota therapeutics. Gastroenterology 146 (2014), 1573–1582.
67. 67 Huang, K.C., Applications of imaging for bacterial systems biology. Curr. Opin. Microbiol. 27 (2015), 114–120.
68. 68 Earle, K.A., et al. Quantitative imaging of gut microbiota spatial organization. Cell Host Microbe. 18 (2015), 478–488.
69. 69 Kostic, A.D., et al. Exploring host-microbiota interactions in animal models and humans. Genes Dev. 27 (2013), 701–718.
70. 70 Kim, H.J., et al. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 12 (2012), 2165–2174.
71. 71 Rusconi, R., et al. Microfluidics expanding the frontiers of microbial ecology. Annu. Rev. Biophys. 43 (2014), 65–91.
72. 72 Englert, D.L., et al. Investigation of bacterial chemotaxis in flow-based microfluidic devices. Nat. Protoc. 5 (2010), 864–872.
73. 73 Wang, Y., et al. In vitro generation of colonic epithelium from primary cells guided by microstructures. Lab Chip 14 (2014), 1622–1631.
74. 74 Gracz, A.D., et al. A high-throughput platform for stem cell niche co-cultures and downstream gene expression analysis. Nat. Cell Biol. 17 (2015), 340–349.
75. 75 Actis, G.C., The gut microbiome. Inflamm. Allergy Drug Targets 13 (2014), 217–223.
76. 76 David, L.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
77. 77 Ding, S., et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS ONE, 5, 2010, e12191.
78. 78 Shoaie, S., et al. Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab. 22 (2015), 320–331.
79. 79 Walsh, C.J., et al. Beneficial modulation of the gut microbiota. FEBS Lett. 588 (2014), 4120–4130.
80. 80 Murphy, E.A., et al. Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk. Curr. Opin. Clin. Nutr. Metab. Care 18 (2015), 515–520.
81. 81 Yatsunenko, T., et al. Human gut microbiome viewed across age and geography. Nature 486 (2012), 222–227.
82. 82 Degnan, P.H., et al. Vitamin B12 as a modulator of gut microbial ecology. Cell Metab. 20 (2014), 769–778.
83. 83 Neu, J., The developing intestinal microbiome: probiotics and prebiotics. World Rev. Nutr. Diet. 110 (2014), 167–176.
84. 84 Ladirat, S.E., et al. Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment. Br. J. Nutr. 112 (2014), 536–546.
85. 85 Watson, D., et al. Selective carbohydrate utilization by lactobacilli and bifidobacteria. J. Appl. Microbiol. 114 (2013), 1132–1146.
86. 86 Vandenplas, Y., et al. Oligosaccharides in infant formula: more evidence to validate the role of prebiotics. Br. J. Nutr. 113 (2015), 1339–1344.
87. 87 Monteagudo-Mera, A., et al. High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome. Benef. Microbes 7 (2016), 247–264.
88. 88 Gao, Z., et al. Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer. Mol. Med. Rep. 12 (2015), 6119–6127.
89. 89 McFarland, L.V., Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open, 4, 2014, e005047.
90. 90 Segers, M.E., Lebeer, S., Towards a better understanding of Lactobacillus rhamnosus GG–host interactions. Microb. Cell Fact., 13(Suppl. 1), 2014, S7.
91. 91 Claes, I.J., et al. Lipoteichoic acid is an important microbe-associated molecular pattern of Lactobacillus rhamnosus GG. Microb. Cell Fact., 11, 2012, 161.
92. 92 Lebeer, S., et al. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat. Rev. Microbiol. 8 (2010), 171–184.
93. 93 Candon, S., et al. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. PLoS ONE, 10, 2015, e0125448.
94. 94 Maura, D., et al. Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine. Antimicrob. Agents Chemother. 56 (2012), 6235–6242.
95. 95 Hraiech, S., et al. Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status. Drug Des. Devel. Ther. 9 (2015), 3653–3663.
96. 96 Ando, H., et al. Engineering modular viral scaffolds for targeted bacterial population editing. Cell Systems 1 (2015), 187–196.
97. 97 Allegretti, J.R., et al. Fecal microbiota transplantation via colonoscopy for recurrent C. difficile infection. J. Vis. Exp., 2014, 10.3791/52154 Published online December 8, 2014.
98. 98 Schloss, P.D., et al. Introducing mothur: open-source, platform-Independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75 (2009), 7537–7541.
99. 99 Mahé, F., et al. Swarm: robust and fast clustering method for amplicon-based studies. PeerJ, 2, 2014, e593.
100. 100 Tikhonov, M., et al. Interpreting 16S metagenomic data without clustering to achieve sub-OTU resolution. ISME J. 9 (2015), 68–80.
101. 101 Callahan, B.J., et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13 (2016), 581–583.
102. 102 Eren, A.M., et al. Oligotyping: differentiating between closely related microbial taxa using 16S rRNA gene data. Methods Ecol. Evol., 2013, 10.1111/2041-210X.12114 Published online December 1, 2013.
103. 103 Eren, A.M., et al. Oligotyping analysis of the human oral microbiome. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), E2875–E2884.
104. 104 Holmes, I., et al. Dirichlet multinomial mixtures: generative models for microbial metagenomics. PLoS ONE, 7, 2012, e30126.
105. 105 Vandeputte, D., et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65 (2016), 57–62.
106. 106 Segata, N., et al. Metagenomic microbial community profiling using unique clade-specific marker genes. Nat. Methods 9 (2012), 811–814.
107. 107 Langille, M.G., et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31 (2013), 814–821.
108. 108 Abubucker, S., et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol., 8, 2012, e1002358.
109. 109 Joice, R., et al. Determining microbial products and identifying molecular targets in the human microbiome. Cell Metab. 20 (2014), 731–741.
110. 110 Bikel, S., et al. Combining metagenomics, metatranscriptomics and viromics to explore novel microbial interactions: towards a systems-level understanding of human microbiome. Comput. Struct. Biotechnol. J. 13 (2015), 390–401.
111. 111 Allali, I., et al. Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain. Gut Microbes. 6 (2015), 161–172.
112. 112 Gevers, D., et al. The Human Microbiome Project: a community resource for the healthy human microbiome. PLoS Biol., 10, 2012, e1001377.
113. 113 Devine, A.A., et al. Impact of ileocecal resection and concomitant antibiotics on the microbiome of the murine jejunum and colon. PLoS ONE, 8, 2013, e73140.
114. 114 Sato, T., Clevers, H., Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science 340 (2013), 1190–1194.
115. 115 Huh, D., et al. Microfabrication of human organs-on-chips. Nat. Protoc. 8 (2013), 2135–2157.
116. 116 Fogh, J., Trempe, G., New human tumor cell lines. Fogh, J., (eds.) Human Tumor Cells In Vitro, 1975, Springer, 115–141.
117. 117 Kim, H.J., Ingber, D.E., Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation. Integr. Biol. (Camb) 5 (2013), 1130–1140.
118. 118 Kim, H.J., et al. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), E7–E15.
119. 119 Forbester, J.L., et al. Interaction of Salmonella enterica serovar Typhimurium with intestinal organoids derived from human induced pluripotent stem cells. Infect. Immun. 83 (2015), 2926–2934.
120. 120 Leslie, J.L., et al. Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function. Infect. Immun. 83 (2015), 138–145.
121. 121 Sierra, C., et al. Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial. Eur. J. Nutr. 54 (2015), 89–99.
122. 122 Giovannini, M., et al. Prebiotic effect of an infant formula supplemented with galacto-oligosaccharides: randomized multicenter trial. J. Am. Coll. Nutr. 33 (2014), 385–393.
123. 123 Ladirat, S.E., et al. Impact of galacto-oligosaccharides on the gut microbiota composition and metabolic activity upon antibiotic treatment during in vitro fermentation. FEMS Microbiol. Ecol. 87 (2014), 41–51.
124. 124 Silva, M., et al. Antimicrobial substance from a human Lactobacillus strain. Antimicrob. Agents Chemother. 31 (1987), 1231–1233.
125. 125 Gueimonde, M., et al. Effect of maternal consumption of Lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. J. Pediatr. Gastroenterol. Nutr. 42 (2006), 166–170.
126. 126 Reyes, A., et al. Going viral: next generation sequencing applied to human gut phage populations. Nat. Rev. Microbiol. 10 (2012), 607–617.
127. 127 Herold, S., et al. Shiga toxin-encoding bacteriophages–genomes in motion. Int. J. Med. Microbiol. 294 (2004), 115–121.
128. 128 Manichanh, C., et al. Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res. 20 (2010), 1411–1419.
129. 129 Kang, D., et al. Vitamin B12 modulates the transcriptome of the skin microbiota in acne pathogenesis. Sci. Transl. Med., 7, 2015, 293ra103.
130. 130 Drumo, R., et al. Salmonella enterica serovar Typhimurium exploits inflammation to modify swine intestinal microbiota. Front. Cell. Infect. Microbiol., 5, 2015, 106.
131. 131 Hur, K.Y., Lee, M.S., Gut microbiota and metabolic disorders. Diabetes Metab. J. 39 (2015), 198–203.
132. 132 Ohtani, N., Microbiome and cancer. Semin. Immunopathol. 37 (2015), 65–72.
133. 133 Bindels, L.B., et al. Towards a more comprehensive concept for prebiotics. Nat. Rev. Gastroenterol. Hepatol. 12 (2015), 303–310.
134. 134 Weingarden, A.R., et al. Changes in colonic bile acid composition following fecal microbiota transplantation are sufficient to control Clostridium difficile germination and growth. PLoS ONE, 11, 2016, e0147210.
135. 135 Meike Samtlebe, F.E., et al. Carrier systems for bacteriophages to supplement food systems: encapsulation and controlled release to modulate the human gut microbiota. LTW–Food Sci. Technol. 68 (2016), 334–340.